Parvovirus B19 Antibody, aa 328-344 of VP2 capsid protein, clone R92F6 | EMD Millipore MAB8293 product information

This webpage contains legacy information. The product is either no longer available from the supplier or has been delisted at Labome.

product summary

company name :

EMD Millipore

other brands :

Oncogene Research Products, Calbiochem, Novagen, Merck, Upstate Biotechnology, Chemicon, LINCO, Novabiochem, Guava

product type :

antibody

product name :

Parvovirus B19 Antibody, aa 328-344 of VP2 capsid protein, clone R92F6

catalog :

MAB8293

quantity :

100 μg

clonality :

monoclonal

host :

mouse

conjugate :

nonconjugated

clone name :

R92F6

reactivity :

human

application :

western blot, ELISA, immunohistochemistry, immunocytochemistry, immunohistochemistry - paraffin section

citations: 18

Published Application/Species/Sample/Dilution	Reference
western blot; human; loading ...; fig 1a	Xu P, Chen A, Ganaie S, Cheng F, Shen W, Wang X, et al. The 11-Kilodalton Nonstructural Protein of Human Parvovirus B19 Facilitates Viral DNA Replication by Interacting with Grb2 through Its Proline-Rich Motifs. J Virol. 2019;93: pubmed publisher
immunohistochemistry; human; 1:200	Page C, Hoffmann T, Benzerdjeb N, Desailloud R, Sevestre H, Duverlie G. Immunohistochemical- and PCR-based assay for the reproducible, routine detection of erythrovirus B19 in thyroid tissues. J Med Virol. 2015;87:1054-9 pubmed publisher
	Ganaie S, Chen A, Huang C, Xu P, Kleiboeker S, Du A, et al. RNA Binding Protein RBM38 Regulates Expression of the 11-Kilodalton Protein of Parvovirus B19, Which Facilitates Viral DNA Replication. J Virol. 2018;92: pubmed publisher
	Bonvicini F, Bua G, Manaresi E, Gallinella G. Antiviral effect of cidofovir on parvovirus B19 replication. Antiviral Res. 2015;113:11-8 pubmed publisher
	Bonvicini F, Mirasoli M, Manaresi E, Bua G, Calabria D, Roda A, et al. Single-cell chemiluminescence imaging of parvovirus B19 life cycle. Virus Res. 2013;178:517-21 pubmed publisher
	Chandramouli S, Medina Selby A, Coit D, Schaefer M, Spencer T, Brito L, et al. Generation of a parvovirus B19 vaccine candidate. Vaccine. 2013;31:3872-8 pubmed publisher
	Winter K, von Kietzell K, Heilbronn R, Pozzuto T, Fechner H, Weger S. Roles of E4orf6 and VA I RNA in adenovirus-mediated stimulation of human parvovirus B19 DNA replication and structural gene expression. J Virol. 2012;86:5099-109 pubmed publisher
	Polcz M, Adamson L, Datar R, Fowler L, Hobbs J. Detection of parvovirus B19 capsid proteins in testicular tissues. Urology. 2012;79:744.e9-15 pubmed publisher
	Chen A, Kleiboeker S, Qiu J. Productive parvovirus B19 infection of primary human erythroid progenitor cells at hypoxia is regulated by STAT5A and MEK signaling but not HIF?. PLoS Pathog. 2011;7:e1002088 pubmed publisher
	Adamson L, Fowler L, Clare Salzler M, Hobbs J. Parvovirus B19 infection in Hashimoto's thyroiditis, papillary thyroid carcinoma, and anaplastic thyroid carcinoma. Thyroid. 2011;21:411-7 pubmed publisher
	Guan W, Cheng F, Huang Q, Kleiboeker S, Qiu J. Inclusion of the central exon of parvovirus B19 precursor mRNA is determined by multiple splicing enhancers in both the exon and the downstream intron. J Virol. 2011;85:2463-8 pubmed publisher
	Pasquinelli G, Bonvicini F, Foroni L, Salfi N, Gallinella G. Placental endothelial cells can be productively infected by Parvovirus B19. J Clin Virol. 2009;44:33-8 pubmed publisher
	Bonvicini F, Filippone C, Manaresi E, Zerbini M, Musiani M, Gallinella G. HepG2 hepatocellular carcinoma cells are a non-permissive system for B19 virus infection. J Gen Virol. 2008;89:3034-8 pubmed publisher
	Bonvicini F, Filippone C, Manaresi E, Zerbini M, Musiani M, Gallinella G. Functional analysis and quantitative determination of the expression profile of human parvovirus B19. Virology. 2008;381:168-77 pubmed publisher
	Modrof J, Berting A, Tille B, Klotz A, Forstner C, Rieger S, et al. Neutralization of human parvovirus B19 by plasma and intravenous immunoglobulins. Transfusion. 2008;48:178-86 pubmed
	Amexis G, Young N. Parvovirus B19 empty capsids as antigen carriers for presentation of antigenic determinants of dengue 2 virus. J Infect Dis. 2006;194:790-4 pubmed
	Ogasawara Y, Amexis G, Yamaguchi H, Kajigaya S, Leppla S, Young N. Recombinant viral-like particles of parvovirus B19 as antigen carriers of anthrax protective antigen. In Vivo. 2006;20:319-24 pubmed
	Lowin T, Raab U, Schroeder J, Franssila R, Modrow S. Parvovirus B19 VP2-proteins produced in Saccharomyces cerevisiae: comparison with VP2-particles produced by baculovirus-derived vectors. J Vet Med B Infect Dis Vet Public Health. 2005;52:348-52 pubmed

product information

Catalog Number :

MAB8293

Subcategory :

Infectious Diseases

Product Name :

Anti-Parvovirus B19 Antibody, aa 328-344 of VP2 capsid protein, clone R92F6

Product Type :

Antibodies

Clonality :

Monoclonal Antibody

Host Name :

Mouse

Antigen :

Parvovirus B19

Clone :

R92F6

Conjugate :

Purified

Isotype :

IgG1

Product Description :

Anti-Parvovirus B19 Antibody, aa 328-344 of VP2 capsid protein, clone R92F6

Cross Reactivity :

Human

Immunogen :

Native parvovirus B19 purified from human plasma.

Specificity :

Recognizes Human parvovirus B19. Recognizes an epitope common to VP1 and VP2 structural proteins of B19. In B19 infected tissues, MAB8293 staining is localized predominantly in the nucleus though cytoplasmic staining may also be observed.

Package Size :

100 μg

Uses :

ELISA;Immunofluorescence;Immunohistochemistry (Paraffin);Western Blotting

Storage :

Maintain for 1 year at 2–8°C from date of shipment. Aliquot to avoid repeated freezing and thawing. For maximum recovery of product, centrifuge the original vial after thawing and prior to removing the cap.